Gut Microbiome May Be Key Variable in Immunotherapy Efficacy Gut Microbiome May Be Key Variable in Immunotherapy Efficacy

Could an impaired or unbalanced microbiome account for a patient ' s failure to respond to immunotherapy?Medscape Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news